A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1

NCT03837353 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
18
Enrollment
OTHER
Sponsor class

Stopped Terminated early due to slow accrual in the context of changing practice patterns.

Conditions

Interventions

Sponsor

NYU Langone Health

Collaborators